 joined the MJH Life Sciences team in October 2020. Follow her on Twitter 

Articles

NM was found to have a stable disease course and the most common classification was typical congenital. 

Characteristics of Nemaline Myopathy Clarified by Cross Sectional Study

Videos

The AASM board of directors member and professor of medicine at UCLA also discussed the relative inefficacy of sleep hygiene therapy for insomnia. 

Challenges of Treating Chronic Insomnia: Jennifer Martin, PhD

, has been with the team since October 2019. Follow him on Twitter 

Hippocampal-sparing and limbic-predominant atrophy were also associated with incident dementia, with faster cognitive decline in the limbic predominant atrophy group. 

Atrophy Subtypes May Predict Cognitive Decline Patterns, Rates of Conversion to Dementia

Trevor J. Resnick, MD, reviews data presented at the American Epilepsy Society (AES) Annual Meeting 2020.

Treating Epilepsy: Key Takeaways From AES 2020

The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine detailed his study on the correlations between sleep and cognitive decline in middle-aged Hispanics.

NeuroVoices: Christian Agudelo, MD, on Sleep’s Impact on Cognitive Decline

New technology enables the collection and analysis of speech behaviors, but this requires an extensive database, which the ADDF seeks to help develop. 

ADDF Calls for Global Partnership to Compile Speech Biomarkers in Early Alzheimer

The calculation of fVPA based on this equation resulted in a misinterpretation in 40% of measurements with around 75% of them overestimating the actual measured fVPA. 

Inaccuracies With Valproic Acid Free Concentration Identified in Status Epilepticus

The director of the Mid-Atlantic Epilepsy and Sleep Center discussed his team’s investigations into predicting responders and adverse events. 

Pavel Klein, MD: Determining Likelihood of Efficacy and AEs in Patient Populations

Including these agents for developmental and epileptic encephalopathies, the relatively young company has 5 programs under development to target rare neurological disorders. 

Praxis Medicines Wins Rare Disease and Orphan Drug Designations for DEEs

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.

All News